Comparison of the long-term prognosis between coronary vasospasm and intermediate vasoconstriction induced by the administration of acetylcholine

Korean Circulation Journal

Volumn 36, Issue 7, 2006, Pages 503-509

  Shin, Dong Il ^a   Seung, Ki Bae ^a   Kim, Dong Bin ^a   Her, Sung Ho ^a   Ham, Joo Ho ^a   Seo, Suk Min ^a   Shin, Woo Seung ^a   Kim, Pum Joon ^a   Chang, Kiyuk ^a   Baek, Sang Hong ^a   Chung, Wook Sung ^a   Kim, Jae Hyung ^a   Hong, Soon Jo ^a   Choi, Kyu Bo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Prognosis; Vasoconstriction; Vasospasm

Indexed keywords

ACETYLCHOLINE; CALCIUM ANTAGONIST; GLYCERYL TRINITRATE; NICORANDIL; NITRATE; VASODILATOR AGENT;

ADULT; ARTERY DIAMETER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY SPASM; DOSE RESPONSE; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROVOCATION TEST; SMOKING HABIT; THORAX PAIN;

EID: 33747805941     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2006.36.7.503     Document Type: Article

References (28)

1. Waters DD, Theroux P, Szlachcic J, et al. Ergonovine testing in a coronary care unit. Am J Cardiol 1980;46:922-30.
2. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction: the case for a distinction. Circulation 1990;81:1983-91.
3. Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 1986;73:865-76.
4. Kaski JC, Maseri A, Vejar M, Crea F, Hackett D. Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J Am Coll Cardiol 1989;14:1456-63.
5. Ihm SH, Seung KB, Chang KY, et al. Morphologic differences in the vessel wall at sites of focal and diffuse coronary vasospasm by intravascular ultrasound (IVUS). Korean Circ J 2001;31:749-56.
6. Kashima K, Tachibana H, Nakamura K, Kano T, Tanaka Y, Arima T. Long-term outcome of patients with ergonovine induced coronary constriction not associated with ischemic electrocardiographic changes. J Cardiol 2001;37:301-8.
7. Okumura K, Yasue H, Matsuyama K, et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988;12:883-8.
8. Sueda S, Kohno H, Fukuda H, et al. Limitations of medical therapy in patients with pure coronary spastic angina. Chest 2003;123:380-6.
9. Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988;78:1-9.
10. Park YB, Lee YW, Kim SH, et al. Coronary artery spasm in patients with coronary artery disease. Korean Circ J 1988;18:161-76.
11. Kim JH, Lim BK, Kim BY, et al. Incidence of eNOS gene mutation in Korean patients with coronary artery spasm. Korean Circ J 2001;31:512-9.
12. Walling A, Waters DD, Miller DD, Roy D, Pelletier GB, Theroux P. Long-term prognosis of patients with variant angina. Circulation 1987;76:990-7.
13. Nobuyoshi M, Abe M, Nosaka H, et al. Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. Am Heart J 1992;124:32-8.
14. Shimokawa H, Nagasawa K, Irie T, et al. Clinical characteristics and long-term prognosis of patients with variant angina: a comparative study between western and Japanese populations. Int J Cardiol 1988;18:331-49.
15. Onaka H, Hirota Y, Shimada S, et al. Prognostic significance of the pattern of multivessel spasm in patients with variant angina. Jpn Circ J 1999;63:509-13.
16. Kishida H, Hata N, Kusama Y, et al. Factors influencing the clinical course and the long-term prognosis of patients with variant angina. Jpn Heart J 1987;28:293-306.
17. Waters DD, Miller DD, Szlachcic J, et al. Factors influencing the long-term prognosis of treated patients with variant angina. Circulation 1983;68:258-65.
18. Severi S, Davies T, Maseri A, Marzullo P, L'Abbate A. Long-term prognosis of "variant" angina with medical treatment. Am J Cardiol 1980;46:226-32.
19. Sueda S, Kohno H, Fukuda H, et al. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis 2004;15:491-7.
20. Goto A, Ito S, Kondo H, et al. Evaluation of adjunctive intracoronary administration of acetylcholine following intravenous infusion of ergonovine to provoke coronary artery spasm. J Cardiol 1999;34:309-16.
21. Asselbergs FW, Monnink SH, Jessurun GA, et al. Assessing the prognostic value of coronary endothelial function in patients referred for a first coronary angiogram. Am J Cardiol 2004;94:1063-7.
22. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.
23. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-8.
24. Jeong JY, Lim DS, Kang JA, et al. The study of coronary spasm by follow-up coronary angiography in variant angina. Korean Circ J 2002;32:791-7.
25. Kaski JC. Variant angina pectoris. In: Crawford MH, DiMarco JP, editors. Cardiology, 1st ed. London: Mosby; 2001. p.271-8.
26. Park SJ, Park SW, Song JK, et al. Clinical, angiographic characteristics and long-term follow-up in patients with variant angina. Korean Circ J 1994;24:349-63.
27. Waters DD, Bouchard A, Theroux P. Spontaneous remission is a frequent outcome of variant angina. J Am Coll Cardiol 1983;2:195-9.
28. Waters DD, Szlachcic J, Theroux P, Dauwe F, Mizgala HF. Ergonovine testing to detect spontaneous remission of variant angina during long-term treatment with calcium antagonist drugs. Am J Cardiol 1981;47:179-84.